Nephrogenic systemic fibrosis (NSF) and gadolinium-based contrast media

SA Journal of Radiology

 
 
Field Value
 
Title Nephrogenic systemic fibrosis (NSF) and gadolinium-based contrast media
 
Creator Ngoya, P.S. Vawda, Z Lotz, J.W
 
Subject Radiology; nephrology Nephrogenic systemic fibrosis; NSF; gadolinium-based contrast agents; GBCA; gadolinium-based contrast media
Description Nephrogenic systemic fibrosis (NSF), unknown before March 1997 and first described in 2000, is a systemic disorder characterised by widespread tissue fibrosis. The first known case occurred in 1997, after the use of gadolinium-based contrast agents (GBCAs) at high doses in patients with renal failure had become routine. An overwhelming majority occurred within weeks to months after injection of a GBCA. This note comprises guidelines on the prevention of NSF.
 
Publisher AOSIS
 
Contributor
Date 2013-08-01
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — —
Format text/html application/pdf
Identifier 10.4102/sajr.v17i3.277
 
Source South African Journal of Radiology; Vol 17, No 3 (2013); 106-107 2078-6778 1027-202X
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajr.org.za/index.php/sajr/article/view/277/354 https://sajr.org.za/index.php/sajr/article/view/277/353
 
Coverage — — —
Rights Copyright (c) 2013 P.S. Ngoya, Z Vawda, J.W Lotz https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT